Granules India Ltd.

GRANULES

₹579.1

1.44% (8.2)

Market Cap

₹13,849 Cr.

P/E

28.90

About

Granules India Limited, a vertically integrated pharmaceutical manufacturing company based in Hyderabad, India, specializes in producing APIs, PFIs, and FDs. Known for its product-focused business mod… Read more

Granules India Limited, a vertically integrated pharmaceutical manufacturing company based in … Read more

Low

389

52W Range

High

721

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days

Price & Performance

Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
ROCE Strength

Roce of the company is consistently strong
Balance Sheet Strength

Balance sheet of the company is strong. it shouldnt have solvency or liquidity issues
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
ROE

Roe has decreased vs 10 year trend
Working Capital

Company has significant working capital which is dragging its roce and roe
Sales Growth

Sales of the company has grown at a slow pace
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Segment Break-Up

Location Wise Break-Up

Operational Metrics

US DMF Filings (.)
Source
Europe DMF Filings (.)
Source
Manufacturing Capacity - Metformin (MTPA)
Source
Manufacturing Capacity - Ibuprofen (MTPA)
Source
Total reactor capacity (kL)
Source
Manufacturing Capacity - Paracetamol (MTPA)
Source
Number of ANDA's Approved By USFDA (.)
Source
Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Filed (.)
Source
Number of ANDA's Approved (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Suppliers

IOL Chemicals And Pharmaceuticals Ltd.

FAQs on Granules India Ltd. Business

What does Granules India do?

Granules India Limited is a high-growth pharmaceutical company in India, specializing in APIs, PFIs, and FDs. It holds a leadership position in generic drugs like Paracetamol and Ibuprofen.

Who are the competitors of Granules India?

Granules India major competitors are Solara Active Pharma, IOL Chem & Pharma, Alivus Life Sciences, AMI Organics, Neuland Laboratories, Shilpa Medicare, Supriya Lifescience.
Market Cap of Granules India is ₹13,849 Crs.
While the median market cap of its peers are ₹7,121 Crs.

Is Granules India financially stable compared to its competitors?

Granules India seems to be less financially stable compared to its competitors.
Altman Z score of Granules India is 5.88 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini					Mar Jun Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec

Discussions & Analysis

Granules India Ltd.

View the discussion on ValuePickr

Granules 2.0 - Manoj Krishna Reddy

Detailed Overview Of Granules India - Tushar Bohra

Quick Walkthrough Of Granules - Tushar Bohra

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Phama Industry - Terminologies and Value Chain - Alpha Invesco

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Granules India Ltd.